Evidence map›Paper›PMID 38140084›Full record

ReviewPharmaceutics2023

4D Printing: The Development of Responsive Materials Using 3D-Printing Technology.

Pablo Edmundo Antezana, Sofia Municoy, Gabriel Ostapchuk, Paolo Nicolás Catalano, John G Hardy, Pablo Andrés Evelson, Gorka Orive, Martin Federico Desimone

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Biomimetic Scaffold-Based 3D Models for Decoding Cancer Biology and Advancing Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pablo Edmundo AntezanaUniversidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de la Química y Metabolismo del Fármaco (IQUIMEFA), Facultad de Farmacia y Bioquímica Junín 956, Piso 3, Buenos Aires 1113, Argentina.
Sofia MunicoyUniversidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de la Química y Metabolismo del Fármaco (IQUIMEFA), Facultad de Farmacia y Bioquímica Junín 956, Piso 3, Buenos Aires 1113, Argentina.ORCID 0000-0002-1383-4093
Gabriel OstapchukInstituto de Nanociencia y Nanotecnología (CNEA-CONICET), Nodo Constituyentes, Av. Gral. Paz 1499 (B1650KNA), San Martín, Buenos Aires 8400, Argentina.ORCID 0009-0003-2063-6794
Paolo Nicolás CatalanoInstituto de Nanociencia y Nanotecnología (CNEA-CONICET), Nodo Constituyentes, Av. Gral. Paz 1499 (B1650KNA), San Martín, Buenos Aires 8400, Argentina.
John G HardyMaterials Science Institute, Lancaster University, Lancaster LA1 4YB, UK.ORCID 0000-0003-0655-2167
Pablo Andrés EvelsonUniversidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Bioquímica y Medicina Molecular (IBIMOL), Facultad de Farmacia y Bioquímica, Buenos Aires 1428, Argentina.ORCID 0000-0001-7920-7968
Gorka OriveNanoBioCel Research Group, School of Pharmacy, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-0773-300X
Martin Federico DesimoneUniversidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de la Química y Metabolismo del Fármaco (IQUIMEFA), Facultad de Farmacia y Bioquímica Junín 956, Piso 3, Buenos Aires 1113, Argentina.ORCID 0000-0002-0571-7962

Funding

Consejo Nacional de Investigaciones Científicas y Técnicas PIBAA 28720210100962COUniversity of Buenos Aires PIDAE2022University of Buenos Aires UBACYT 20020150100056BA
6 · The paper itself

Abstract

Additive manufacturing, widely known as 3D printing, has revolutionized the production of biomaterials. While conventional 3D-printed structures are perceived as static, 4D printing introduces the ability to fabricate materials capable of self-transforming their configuration or function over time in response to external stimuli such as temperature, light, or electric field. This transformative technology has garnered significant attention in the field of biomedical engineering due to its potential to address limitations associated with traditional therapies. Here, we delve into an in-depth review of 4D-printing systems, exploring their diverse biomedical applications and meticulously evaluating their advantages and disadvantages. We emphasize the novelty of this review paper by highlighting the latest advancements and emerging trends in 4D-printing technology, particularly in the context of biomedical applications.

Indexed as

3D printing4D printingdrug deliverysmart materialsstimuli responsive materials

Identifiers

PMID38140084
PMCPMC10747900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.